Literature DB >> 18259975

COPD: a pediatric disease.

Andrew Bush1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is conventionally thought of as a disease of adult smokers, related to airway inflammation and structural airway changes (remodeling). However, there is important epidemiological evidence, from a series of studies with overlapping age groups from birth to late middle age that early life events, including antenatal influences on lung growth, program the child to be at increased risk for future COPD. This paper reviews the evidence for potential gene: environment interactions in this process, in particular with respect to the maternal genotype of the COPD patient. It explores the hypothesis that genes important in early lung development are also important in determining adult risk for COPD. Although the major preventable factor adversely impacting on child lung health is maternal smoking, the effects of viral infection, nutrition, and indoor and outdoor pollution are reviewed. The survivors of preterm birth are another important cohort who may develop premature COPD in adult life. Early life events provide the substrate for COPD, with later cigarette smoking, and occasionally other exposures, pulling the trigger to produce COPD. Although a rigorous anti-smoking program is necessary to halt this spiral of lung destruction leading to COPD, a focus on early (including prenatal) lung health is also important. Any model of COPD which does not take into account early life influences is likely to be fatally flawed.

Entities:  

Mesh:

Year:  2008        PMID: 18259975     DOI: 10.1080/15412550701815965

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  27 in total

Review 1.  Relevance of birth cohorts to assessment of asthma persistence.

Authors:  Robert J Hancox; Padmaja Subbarao; Malcolm R Sears
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

Review 2.  Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.

Authors:  Urs Frey; Béla Suki
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

3.  Neonatal hyperoxia contributes additively to cigarette smoke-induced chronic obstructive pulmonary disease changes in adult mice.

Authors:  Sharon A McGrath-Morrow; Thomas Lauer; J Michael Collaco; Min Yee; Michael O'Reilly; Wayne Mitzner; Enid Neptune; Robert Wise; Shyam Biswal
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-14       Impact factor: 6.914

4.  Developmental origins of colon smooth muscle dysfunction in IBS-like rats.

Authors:  Qingjie Li; John H Winston; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

5.  Different forms of adiponectin reduce the apoptotic and damaging effect of cigarette smoke extract on human bronchial epithelial cells.

Authors:  Meng-Yu Cheng; Hu Liu; Tie-Mei Zhang; Jian-Ying Xu
Journal:  Exp Ther Med       Date:  2016-11-04       Impact factor: 2.447

Review 6.  Impact of environmental chemicals on lung development.

Authors:  Mark D Miller; Melanie A Marty
Journal:  Environ Health Perspect       Date:  2010-05-05       Impact factor: 9.031

7.  Obstructive pulmonary disease in old age among individuals born preterm.

Authors:  Eva Berggren Broström; Olof Akre; Miriam Katz-Salamon; David Jaraj; Magnus Kaijser
Journal:  Eur J Epidemiol       Date:  2013-01-23       Impact factor: 8.082

Review 8.  The origins of asthma and chronic obstructive pulmonary disease in early life.

Authors:  Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2009-05-01

Review 9.  Asthma and chronic obstructive pulmonary disease.

Authors:  Stefano Guerra
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-10

10.  Lung volume, breathing pattern and ventilation inhomogeneity in preterm and term infants.

Authors:  Philipp Latzin; Stefan Roth; Cindy Thamrin; Gerard J Hutten; Isabelle Pramana; Claudia E Kuehni; Carmen Casaulta; Matthias Nelle; Thomas Riedel; Urs Frey
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.